Literature DB >> 18351647

Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma.

Yanting Qi1, Xiaona Chen, Chu-yan Chan, Dan Li, Chonggang Yuan, Fei Yu, Marie C Lin, David T Yew, Hsiang-Fu Kung, Lihui Lai.   

Abstract

Diethylnitrosamine (DEN) is a known carcinogen that can alkylate DNA molecules. In rats, DEN-induced hepatocellular carcinoma (HCC) model is well established. In this study, we used a two-dimensional differential gel electrophoresis (2D-DIGE) system and liquid chromatography/mass spectrometry/mass spectrometry to identify the differential expression protein profiles between the DEN-induced HCC and healthy liver cells. Western blotting and semiquantitative RT-PCR were used to further confirm the results. Seventeen differentially expressed spots were identified in DEN-induced HCC cells. Among all, the most prominent upregulated proteins include the members of the glutathione S-transferase super family, aldo-keto reductase superfamily and proteins involved in the response to oxidative stress. Downregulation was observed in 2 proteins that were known to contribute to hepatic dysfunction. This study provides the first comprehensive protein profiling of the DEN-induced HCC in rats. This model simulates the differential protein expression of human HCC and may be useful for further understanding the mechanism of HCC tumorigenesis. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351647     DOI: 10.1002/ijc.23464

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Preventive Effects of Vitamin C on Diethylnitrosamine-induced Hepatotoxicity in Smp30 Knockout Mice.

Authors:  Young-Sook Son; H M Arif Ullah; Ahmed K Elfadl; Myung-Jin Chung; Soong-Gu Ghim; Yong Deuk Kim; Eun-Joo Lee; Kyung-Ku Kang; Kyu-Shik Jeong
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

2.  Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis.

Authors:  Yexiong Tan; Peiyuan Yin; Liang Tang; Wenbin Xing; Qiang Huang; Dan Cao; Xinjie Zhao; Wenzhao Wang; Xin Lu; Zhiliang Xu; Hongyang Wang; Guowang Xu
Journal:  Mol Cell Proteomics       Date:  2011-11-14       Impact factor: 5.911

3.  Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway.

Authors:  Amita Verma; Deepika Singh; Firoz Anwar; Prakash Chandra Bhatt; Fahad Al-Abbasi; Vikas Kumar
Journal:  Inflammopharmacology       Date:  2017-06-12       Impact factor: 4.473

Review 4.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

Review 5.  Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma.

Authors:  Kwang Il Kim; Hye Kyung Chung; Ju Hui Park; Yong Jin Lee; Joo Hyun Kang
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

6.  Thyroid hormone suppresses hepatocarcinogenesis via DAPK2 and SQSTM1-dependent selective autophagy.

Authors:  Hsiang-Cheng Chi; Shen-Liang Chen; Chung-Ying Tsai; Wen-Yu Chuang; Ya-Hui Huang; Ming-Ming Tsai; Sheng-Ming Wu; Cheng-Pu Sun; Chau-Ting Yeh; Kwang-Huei Lin
Journal:  Autophagy       Date:  2016-09-21       Impact factor: 16.016

Review 7.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

8.  Protective effects and potential mechanisms of Pien Tze Huang on cerebral chronic ischemia and hypertensive stroke.

Authors:  Lihong Zhang; Wai Ping Lam; Lanhai Lü; Chunmei Wang; Yeuk Wa Wong; Lok Hang Lam; Hong Chai Tang; Maria Sen Mun Wai; Mingwei Wang; Wing Hang Kwong; Sai Ming Ngai; Ying Tat Mak; David Tai Wai Yew
Journal:  Chin Med       Date:  2010-10-18       Impact factor: 5.455

9.  Accelerated hepatocellular carcinoma development in CUL4B transgenic mice.

Authors:  Jupeng Yuan; Baichun Jiang; Aizhen Zhang; Yanyan Qian; Haining Tan; Jiangang Gao; Changshun Shao; Yaoqin Gong
Journal:  Oncotarget       Date:  2015-06-20

10.  A disturbance rejection framework for the study of traditional chinese medicine.

Authors:  Han Zhang; Yan Sun; Zhiqiang Gao; Yueqi Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.